DIDS4-PBALiver fibrosis
…TGF-β1-induced HSC activation. In murine liver fibrosis models, DIDS administration significantly ameliorated liver fibrosis, concur…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 541–600 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
N-Acetyl Cysteine7PPIs7Streptozotocin7fondaparinux7high-dose corticosteroids7hydroxyurea7naltrexone7tyrosine kinase inhibitors7vaccines7SGLT-2i6Glipizide6BLV6Varenicline6Camrelizumab6Cancer Drugs6Benzene6Doxy-PEP6SGLT-2is6Aprepitant6DEX6Dostarlimab6T-DXd6Azacitidine6Esketamine6NAC6Fidaxomicin6ITM6Minocycline6N-acetylcysteine6pMDIs6NBCA6Clofazimine6Filgotinib6Ravulizumab6Atomoxetine6Methylphenidate6amoxicillin-clavulanate6Acetylcysteine6Triamcinolone6anti-PD16Nitrous oxide6Octreotide6injectate6IL-1β6Lenalidomide6OAC6Venetoclax6antihypertensive drugs6n-BCA6Anti-TNF6Golimumab6Placebo6aripiprazole6b/tsDMARDs6Lansoprazole6MDPV6Mitomycin C6Nalbuphine6PCSK9 inhibitors6Sodium-Glucose Co-Transporter 2 Inhibitors6
Articles mentioning drugs
10,506 articles · page 223 of 876chloroquineDHACETSAMetabolic dysfunction-associated fatty liver disease (MAFLD)MAFLDhepatic steatosis
…iglycerides and total cholesterol measurements, while CETSA and chloroquine treatment validated protein binding and stability.Results Analy…
GastrodinLiver fibrosiscirrhosischronic liver disease
…ses confirmed that gastrodin targets both processes.Conclusions Gastrodin exerts anti-fibrotic effects by dually inhibiting the TGF-β/SMA…
LPF-01gastric cancerchronic atrophic gastritisGC
…phic gastritis was established using SA, and interventions with LPF-01 and the enteric-derived Lactobacillus plantarum (ATCC strain) w…
MK-1602oxaliplatincolorectal cancerCRC
…ng to senescence escape. Pharmacological targeting of M7CK with MK-1602 (a novel inhibitor identified by virtual screening, KD = 6.49 μ…
dulaglutidetirzepatidesemaglutidemetabolic diseasechronic pancreatitis (CP)CP
… with CP (ICD-10-CM K86.0/K86.1) were classified by exposure to dulaglutide, semaglutide, or tirzepatide (GLP1a cohort) versus no GLP-1 ana…
GLP-1 receptor agonistGLP-1 receptor agonistspancreatic cancertype 2 diabetes mellitusT2DMTriNetX Collaborative Networkrecurrent acute pancreatitischronic pancreatitis
… healthcare organizations). Adults with CP and T2DM receiving a GLP-1 receptor agonist were compared with adults with CP and T2DM without GLP-1 recept…
A. muciniphilaAkkermansia muciniphilaRefractory epilepsyepilepsyWMTwashed microbiota transplantation
…clinical and preclinical findings, this study demonstrates that A. muciniphila synergistically enhances the effects of WMT against epileptic s…
Upadacitinibulcerative colitisCrohn’s diseaseDTT-IBDUCinflammatory bowel disease
…t-to-treat inflammatory bowel disease (DTT-IBD) is challenging. Upadacitinib, an oral Janus kinase 1 inhibitor, has demonstrated efficacy in…
stimulant laxativeslaxativesconstipation
…ty, efficacy and potential for misuse, with a specific focus on stimulant laxatives. In summary, this review enhances awareness and knowledge of th…
FLT3LFLT3L-cDC1 ISVFLT3L-cDC1Non-small cell lung cancerNSCLCTCGA
… cDC1s engineered to secrete FMS-like tyrosine kinase 3 ligand (FLT3L) would enhance cDC1 function within the TME, promote antitumor …
smart inhalersasthma
…rs that must be addressed prior to widespread implementation of smart inhalers. Targeted strategies that address these barriers will be essent…